# Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

> **NCT05660694** · PHASE4 · COMPLETED · sponsor: **Altamash Institute of Dental Medicine** · enrollment: 40 (actual)

## Conditions studied

- Triamcinolone
- Pentoxifylline
- Vitamin E
- Oral Submucosa Fibrosis
- Tumor

## Interventions

- **DRUG:** Triamcinolone
- **DRUG:** Pentoxifylline with Vitamin E

## Key facts

- **NCT ID:** NCT05660694
- **Lead sponsor:** Altamash Institute of Dental Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05660694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05660694, "Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05660694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*